在中精确的神经调节:从共享目标到个性化电路
1Department of Neurology, University of Minnesota Comprehensive Epilepsy Program, University of Minnesota, MINCEP, Minneapolis, MN 55455, USA.
Brain communications
|September 22, 2025
概括
这篇评论讨论了治疗的甲状腺皮层网络的神经调制. 它探讨了如何准这些大脑电路为管理提供了一个有希望的途径.
科学领域:
- 神经科学是一个神经科学.
- 发病学 (Epileptology) 是一个专业的学科.
- 神经调节是一种神经调节.
背景情况:
- 是一种神经系统疾病,其特点是经常性发作.
- 甲状腺皮层网络在发作和发作传播方面发挥着至关重要的作用.
- 目前的治疗有局限性,需要新的治疗策略.
研究的目的:
- 评论Agashe等人对该研究的评论. 关于治疗的甲状腺皮层网络神经调节.
- 突出针对发症治疗的甲状腺皮质电路的潜力.
- 讨论神经调节技术在治疗方面的影响.
主要方法:
- 对Agashe等人提出的调查结果的审查和分析.
- 讨论适用于thalamocortical网络的神经调制技术.
- 综合有关病理生理学和治疗的当前知识.
主要成果:
- 阿加什等人. 阿加什等人. 证明调节甲状腺皮层网络的可行性.
- 神经调节提供了一种有针对性的方法来破坏活动.
- 这种方法有可能改善的控制.
结论:
- thalamocortical网络神经调节代表了研究的重大进展.
- 针对这些特定的大脑网络可能会导致更有效的疗法.
- 对神经调节技术的进一步研究有必要用于的临床应用.
更多相关视频
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
9.3K
06:28Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
Published on: September 27, 2024
3.2K
相关概念视频
01:24Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
831
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
831